Cancer Treatment Today » Liver Cancer

Laparascopic liver resection for benign lesions

M Levin, MD — Fri, 24 Aug 2012 17:02:52 +0000

It is a fairly rare for benign liver lesions to cause pain and there are no specific guidelines for how to treat such situations. However, the literature contains many reports of laparoscopic partial liver resections for non-cancer diagnosis. In experienced hands, laparoscopic liver resection is a favorable alternative to open resection. Surgical morbidity and mortality and long-term survival after laparoscopic resection appear to be comparable to those after open resections.

Read the Professional version here.

Primary Sclerosing Cholangitis (PSC)

M Levin, MD — Tue, 17 Jul 2012 14:33:49 +0000

Primary sclerosing cholangitis (PSC) is a chronic, liver disease characterized by bile stasis within bile ducts and liver inflammation and fibrosis. It is thought to be an immune mediated, progressive disorder that eventually develops into liver cirrhosis, portal hypertension and hepatic decompensation, in the majority of patients. How does one follow the activity of this disease? Guidelines do not recommend routine MRCP or ERCP to screen for screening for cholangio or hepatocellular(liver) carcinoma. They do recommend these tests for patients with deterioration in their constitutional performance or worsening liver tests. These patients should have these tests to evaluate for a possible chalangiocarcinoma.

Routine MCP or ERCP Surveillance for Cholagniocarcinoma or Liver Cancer in Patients with Primary Biliary Cirrhosis.

M Levin, MD — Wed, 20 Jun 2012 22:09:44 +0000

Primary sclerosing cholangitis (PSC) is a chronic, cholestatic liver disease characterized by inflammation and fibrosis of both intrahepatic and extrahepatic bile ducts. It is thoughtto be an immune mediated, progressive disorder that eventually develops into cirrhosis, portal hypertension and hepatic decompensation, in the majority of patients. Guidelines do not recommend routine MRCP or ERCP to screen for chalngiocarcinoma or hepatocellular carcinoma. They do recommend that patients with deterioration in their constitutional performance status or liver biochemical-related parameters should undergo an evaluation for CCA.

Read the Professional version here.